Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Quanyao Network Pharmaceutical is a leading pharmaceutical supply chain and procurement platform in China, operating the 'Quanyao Network' (全药网). Established in 2016 as part of the Shenzhen Neptunus Group, the company serves as a centralized Group Purchasing Organization (GPO) for public medical institutions, notably pioneering the 'Shenzhen Model' of drug procurement. It leverages a massive pharmaceutical database and an internet-based bidding and transaction system to reduce drug prices and improve supply chain efficiency. The platform facilitates billions of RMB in annual transactions, serving thousands of healthcare providers and streamlining the distribution of essential medicines across Guangdong province and beyond.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Quanyao Network Pharmaceutical.